Windlas Biotech Limited Asset Resilience Ratio

Latest as of September 2025: 32.06%

Windlas Biotech Limited asset resilience ratio. Windlas Biotech Limited (WINDLAS) has an Asset Resilience Ratio of 32.06% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See WINDLAS days of operational coverage to measure how many days the company can operate on defensive assets alone.

Liquid Assets

Rs2.61 Billion

≈ $28.23 Million USD Cash + Short-term Investments

Total Assets

Rs8.14 Billion

≈ $88.05 Million USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio of Windlas Biotech Limited (2018–2025)

Asset resilience ratio of Windlas Biotech Limited from 2018 to 2025. This chart shows how Windlas Biotech Limited's Asset Resilience Ratio has changed over time. Read total liabilities of Windlas Biotech Limited for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Windlas Biotech Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see balance sheet size of Windlas Biotech Limited.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	Rs0.00	0%
Short-term Investments	Rs2.61 Billion	32.06%
Total Liquid Assets	Rs2.61 Billion	32.06%

Asset Resilience Insights

Very High Liquidity: Windlas Biotech Limited maintains exceptional liquid asset reserves at 32.06% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

Windlas Biotech Limited Industry Peers by Asset Resilience Ratio

Compare Windlas Biotech Limited's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Takeda Pharmaceutical Company Limited F:TKDA	Drug Manufacturers - Specialty & Generic	0.69%
Takeda Pharmaceutical Co Ltd ADR NYSE:TAK	Drug Manufacturers - Specialty & Generic	4.94%
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt F:RIG2	Drug Manufacturers - Specialty & Generic	0.20%
Ajanta Pharma Limited NSE:AJANTPHARM	Drug Manufacturers - Specialty & Generic	14.99%
Changchun High & New Technology Industries Group Inc SHE:000661	Drug Manufacturers - Specialty & Generic	5.50%
Jiangsu Nhwa Pharmaceutical Co Ltd SHE:002262	Drug Manufacturers - Specialty & Generic	26.45%
Porton Fine Chemicals Ltd SHE:300363	Drug Manufacturers - Specialty & Generic	6.85%
Jubilant Pharmova Limited NSE:JUBLPHARMA	Drug Manufacturers - Specialty & Generic	1.26%

Windlas Biotech Limited Asset Resilience Ratio by Year (2018–2025)

Windlas Biotech Limited asset resilience ratio by year from 2018 to 2025. The table below shows the annual Asset Resilience Ratio data for Windlas Biotech Limited.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-03-31	31.54%	Rs2.40 Billion ≈ $25.94 Million	Rs7.60 Billion ≈ $82.24 Million	-0.25pp
2024-03-31	31.79%	Rs1.99 Billion ≈ $21.53 Million	Rs6.26 Billion ≈ $67.72 Million	+7.54pp
2023-03-31	24.25%	Rs1.28 Billion ≈ $13.87 Million	Rs5.29 Billion ≈ $57.21 Million	-11.48pp
2022-03-31	35.73%	Rs1.75 Billion ≈ $18.97 Million	Rs4.91 Billion ≈ $53.10 Million	+22.79pp
2021-03-31	12.94%	Rs383.25 Million ≈ $4.14 Million	Rs2.96 Billion ≈ $32.02 Million	+6.27pp
2020-03-31	6.67%	Rs225.86 Million ≈ $2.44 Million	Rs3.38 Billion ≈ $36.61 Million	-0.45pp
2019-03-31	7.12%	Rs212.41 Million ≈ $2.30 Million	Rs2.98 Billion ≈ $32.25 Million	-0.76pp
2018-03-31	7.88%	Rs228.53 Million ≈ $2.47 Million	Rs2.90 Billion ≈ $31.35 Million	--

pp = percentage points

About Windlas Biotech Limited

NSE:WINDLAS India Drug Manufacturers - Specialty & Generic

Market Cap

$226.67 Million

Rs20.96 Billion INR

Market Cap Rank

#15821 Global

#810 in India

Share Price

Rs994.40

Change (1 day)

+7.94%

52-Week Range

Rs718.35 - Rs1154.75

All Time High

Rs1154.75